Enovis launches AltiVate Reverse Glenoid System with modular baseplates
The AltiVate Reverse Glenoid System, designed based on Enovis’ central screw fixation design, received the US Food and Drug Administration (FDA) 510(k) approval in May 2024, for use in reverse shoulder arthroplasty, including revisions